Post My Press Release

Free Press Release Distribution

Author: rohit009 (Page 2 of 4)

Global cancer biomarkers market Competitive Landscape, Trends shaping in Healthcare Developing Business

cancer biomarkers market is one of the leading causes of death across the globe. The early stage cancer is diagnosed with the help of biomarkers that are molecules, proteins, or processes indicating the presence of cancerous cells and biological state of tumors in the body. As per the report that has been published by Market Research Future (MRFR), the global cancer biomarkers market is anticipated to expand remarkably at a noteworthy CAGR of 15.8% during the forecast period of 2017-2023.

key players in the global cancer biomarkers market that are profiled in the report published by MRFR are F. Hoffmann-La Roche AG (Switzerland), Becton Dickinson (U.S.), Abbott Laboratories (U.S.), PerkinElmer, Inc. (U.S.), Bristol-Myers Squibb (U.S.), Bio-Rad Laboratories (U.S.), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), GlaxoSmithKline Plc. (U.S.), QIAGEN N.V (U.S.), Novartis AG (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Illumina Inc. (U.S.) and others.

Get Sample For this Report at: https://www.marketresearchfuture.com/sample_request/6243

Market Segmentation:

The global cancer biomarkers market is segmented on the basis of types intoprotein biomarkers, genetic biomarkers and others.

Based on application, the cancer biomarkers market is segmented into diagnostic, prognostic and therapeutic.

The diagnostic segmented is sub-segmented into imaging and non-imaging.

Based on end-users, the cancer biomarkers market is segmented into pharmaceutical and biotechnology companies, diagnostic tool companies, healthcare it/big data companies, clinical laboratories. 

Market Drivers and Restraints:

Rise in prevalence of cancer and extensive research in biomarkers by various research institutes are some of the major factors driving the growth of the global cancer biomarkers market. Extensive application of cancer biomarkers for diagnosis and identification of early-stage cancer, risk assessment, prognosis and treatment predictions, monitoring treatment response and others are fueling the growth of the global cancer biomarkers market.

The increasing use of biomarkers in cancer research for development of effective new drugs and increasing application of cancer biomarkers in the area of surrogate endpoints are positively impacting the growth of the global cancer biomarkers market. Proliferation in government initiatives and funding for development of novel cancer diagnostic techniques is acting as one of the major drivers for the expansion of the global cancer biomarkers market.

Increasing adoption of advanced technology for research and development of highly effective drugs and accurate diagnosis of cancer are anticipated to fuel the growth of the global cancer biomarkers market. However, high cost of development and validation of biomarkers, reluctance in adoption of advanced technology and low detection rate are likely to act as restraints on the growth of the global cancer biomarkers market.

Brows full Detailed copy of Report @ https://www.marketresearchfuture.com/reports/cancer-api-market-6243

Regional Analysis:

The global cancer biomarkers market is regionally segmented into North America, South America, Europe, Asia Pacific and the Middle East and Africa. The North America region is anticipated to account for the largest share in the global cancer biomarkers market owing to the high prevalence of cancer and rapid advancement in the field of cancer biomarkers for development of new drugs and efficient diagnostic procedures in this region.

Increasing number of clinical trials and rise in government funding for discovery and development of new biomarkers are leading to the significant growth of the cancer biomarkers market in the Europe region. Whereas, the market in the Asia Pacific region is anticipated to project fastest growth in the global cancer biomarkers market during the forecast period. The cancer biomarkers market in this region is majorly driven by high investments in cancer diagnosis and treatment by public and private sectors and increasing prevalence of cancer. The cancer biomarkers market in the Middle East and Africa region is projecting slow growth owing to the less penetration of advanced diagnostics and treatment facilities and lack of awareness in the underdeveloped areas of this region.

Competitive Analysis:

The players in the global cancer biomarkers market are increasing the research and development funding for introducing new biomarkers that would help in accurate diagnosis and development of new drugs for treating cancer. The recent discoveries and developments are strengthening the competition among the players and simultaneously fueling the growth of the global cancer biomarkers market.

In July 2018, researchers from University of Delhi and National Institute for Cancer Prevention and Research, Noida (India), have identified two proteins, survivin and STAT3, as potential biomarkers for gastric cancer progression.

Inquire for discount at: https://www.marketresearchfuture.com/check-discount/6243

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

MRFR Report 2018-Nutraceutical Excipients Market Global value at USD 4818.70 Mn. by 2023

Nutraceutical Excipients Market is growing pervasively. The market growth is mainly driven by the burgeoning nutraceutical sector.

In 2017, the market had reached USD 3104.96 Mn and is expected to value at USD 4818.70 Mn. by 2023. Excipients are inactive components added to nutraceuticals during its production to help stabilize the ingredients. Nutraceutical excipients perceive augmenting demand, which in turn, substantiates its market size globally.

Key players operating in the global Nutraceuticals Excipients market include Cargill Corporation, Ingredion, Associated British Foods plc., Kerry, Roquette Freres SA, JRS PHARMA, Innophos, Inc., DowDupont, Sensient Technology Corporation, and Hilmar Ingredients among others.

The probiotics & prebiotics segment, in 2017, accounted for 47.5% of the market share, valuing at USD 1476.17 Mn. The segment is forecasted to register a strong growth during the estimated period. The vitamins & minerals segment is likely to post a CAGR of 7.92% during the review period.

Brows Full Copy of Report @  https://www.marketresearchfuture.com/reports/nutraceutical-excipients-market-6097

Nutraceuticals are dietary supplements that assist in the treatment and prevention of diseases. Medical practitioners advise nutraceuticals so as to provide medical benefits during the treatments for chronic diseases and disorders such as COPD, asthma, cancer, certain heart problems, and diabetes. Increasing prevalence of chronic diseases leads to increase sales of Nutraceuticals, further driving its market growth of Excipients.

Global Nutraceutical Excipients Segmental Analysis:-

On the basis of types, the market is segmented into artificial and natural/organic. In 2017, The artificial segment accounted for the largest market share. This segment is projected to expand at 7% CAGR during the forecast period. However, the natural/organic segment is projected to exhibit a relatively higher CAGR during the review period.

On the basis of functions, the market is segmented into fillers, diluents & bulking agents, binders, disintegrants, sweeteners, coating agents, lubricants, and colors & flavors. Out of these, the fillers, diluents & bulking segment accounted for the largest market share in 2017. On the basis of forms, the market is segmented into dry and liquid. In 2017, the dry segment accounted for 55% of the market share and stood at over USD 1700 Mn. The segment is forecasted to witness a healthy CAGR during the assessment period.

On the basis of Applications, the market is segmented into Probiotics & Prebiotics, Proteins & Amino Acids, Omega-3 Fatty Acids, and Vitamins & Minerals.

Improving economy is undoubtedly one of the key factors propelling the market growth, increasing the quality of life and access to the healthcare. Additionally, factors such as increasing awareness among consumers towards the advantages of Nutraceuticals, expand the growth of nutraceutical excipients market.

On the other hand, some excipients, can initiate or participate in chemical and physical interactions, compromising the efficacy of a nutraceutical.  Hence, the regulatory bodies standardize manufacturing and distribution processes of nutraceuticals. They scrutinize the type, quality, and the amount of ingredients added in a nutraceutical, and the labeling criteria for various ingredients that are to be mentioned on product labels.

These stringent regulations present a number of challenges to the manufacturers limiting the production of nutraceuticals and hence slowing down the consumption and the market growth of excipients used in nutraceuticals.

Regional Analysis: –

Globally, the North America market dominates the nutraceutical excipients market. Increasing prevalence of respiratory diseases and chronic diseases drives the market growth in the region. The sedentary lifestyle is the primary factor fuelling the incidences of chronic diseases.

Also, other factors like the rising geriatric population, increasing healthcare expenditure, coupled with the growing awareness among people towards the benefits of healthy diet, are increasing sales of nutraceutical and hence the market growth of nutraceutical excipients in the region.

The Europe market accounts for the second-largest market for the Nutraceutical excipients owing to the presence of well-established players and growing healthcare expenditures in the region. Certainly, the resurging economy is the main driving force increasing the market value in the region.

The Asia Pacific nutraceutical excipients market emerging as the fastest growing market accounts for a substantial market share on the global platform. Factors such as the proliferation of healthcare sector in populous countries such as India and China substantiate the market growth in the region. 

Get Sample For this Report at: https://www.marketresearchfuture.com/sample_request/6097

Increasing geriatric populace, rising cases of patients suffering from the chronic diseases, growing awareness about the healthcare, and increasing demand for sports nutrition & health supplements influence the market growth positively.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

3D cell culture market

3D cell culture market will emerge as the largest segment with 25.75% of Cagr till 2023

Global 3D Cell Culture Market Research Report: Medical science has achieved remarkable breakthroughs over the years and is still achieving. The technology of tissue regeneration has enabled the growth and repair of cells in the human body. The technique known as 3D cell culture helps biological cells to grow or interact with their surroundings in all three dimensions. Due to 3D cell culture providing more accurate data and more physiologically relevant information in vivo tests, it has become acceptable in comparison to 2D Cell culture.

The key players in the global 3D cell culture market include Becton-Dickinson and Company (USA), Charles River Laboratories Inc (USA), Corning Incorporated (USA), The Electrospinning Company (UK), InSphero, AG (Switzerland), Kuraray Co Ltd (Japan), Lonza (Switzerland), Lena Biosciences Inc. (USA), Merck KGaA (Germany), Tecan Trading AG (Switzerland), ReproCELL Europe Ltd (UK), and Thermo Fisher Scientific Inc. (USA).

Latest Industry News

  • ALPCO, a leading producer of research and clinical immunoassays, has announced its partnership with InSphero, AG. This partnership aims to provide customers with a complete solution to assess beta-cell function in islet micro tissue culture models. 24 JUL 2018
  • Collaborating with the University of Strathclyde, Biotechnology giant AMSBIO has set up a new joint venture company called ScreenIn3D, exploiting the latest advances in microfluidics and 3D cell culture, to develop a novel microfluidic screening platform. 6 JUL 2018.

Get Sample for this Report at: https://www.marketresearchfuture.com/sample_request/5928

To develop the field of tissue engineering in order to regenerate damaged tissues, the cells from the body are combined with highly porous scaffold biomaterials that act as templates for tissue regeneration and guides the growth of new tissue. A technique based on scaffold biomaterials is called scaffolds based on 3D cell culture. Scaffold-free methods include the use of hanging drop plates, low adhesion plates, magnetic 3D bioprinting, magnetic levitation, micropatterned surfaces, and rotating bioreactors.

Some factors that drive the growth of the global 3D cell culture market include organ and tissue regeneration capability and providing drug toxicology screening. Other factors contributing to the rapid growth of this market include rising approval from government bodies, growing awareness, increasing the incidence of cancer and rising demand for organs transplantation and lastly the varying applications of 3D cell culture in biotech and pharmaceutical industry and rising prevalence of cancer worldwide. Demand for organ transplant has risen due to increasing prevalence of organ failures.

The key findings of this report mention that by the end of forecast period, by product segmentation, consumables will be the highest growing segment of the global 3D cell culture market, with a CAGR of 25.88%. At the same time, among application, drug discovery will emerge as the largest segment with 25.75%. As a whole segment, The Pharmaceutical & Biotechnology Companies is expected to witness maximum growth with the CAGR of 26.13%.

The global 3D cell culture market has been segmented into the application, end user, product, technique, and lastly region. Based on application, this market has been segmented into cancer research, drug discovery, regenerative medicine, stem cell research, tissue screening & engineering, and others. Drug discovery is the process that helps the researchers to discover new candidate medications. Regenerative medicine is defined as a branch of translational research in molecular biology and tissue engineering.

Evolution of cell-culture models from simple two-dimensional to complex three-dimensional bioprinted models. Currently, 3D bio-printing is the most sophisticated technique used to make tissue/organ constructs

It deals with the process to replace, engineer or regenerate human cells, tissues or organs in order to restore or establish normal function. The process of borrowing cells from developed organs of the body and used for repairing unhealthy organs is called stem cell research. The purpose of tissue engineering is to assemble the functional constructs that heel, maintain and restore the damaged tissues or whole organs.

On the basis of end users, the global 3D cell culture market has been segmented into contract research organizations, pharmaceutical & biotechnology companies, research & academic laboratories and others. Contract research organizations provide support to the biotechnology, medical device, and pharmaceutical industries in the form of research services outsourced on a contract basis. Based on products, the market has been segmented into consumables and instruments. Consumables include products like vials, cotton buds, cleaning materials, plastic funnels, etc. Instruments include devices that are used for surgeries and activities like removing the tumor. On the basis of technology, the market has been segmented into scaffolds based 3D cell culture and scaffold-free 3D cell culture.

Brows full Detailed Report @ https://www.marketresearchfuture.com/reports/3d-cell-culture-market-5928

The regional segmentation of the global 3D cell culture market covers The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). With many key players based in the United States of America (USA) and due to the availability of advanced technology, North America is a bigger market than South America. In the USA, maximum organ transplant surgeries have taken place since 2016. In Europe, due to reasons same as North America, being more advanced technologically, Western Europe is a bigger market than Eastern Europe.

In the Asia Pacific region, some countries like Japan and Singapore are technologically advanced. And in countries like India and China, the technological advancement is taking place at a slow but steady pace. This is primarily due to less expenditure (compared to governments in Western countries) from governments on medical healthcare. Other countries of Asia Pacific that are strong markets for 3D cell culture include Australia and South Korea, followed by rest of Asia Pacific countries. In the MEA countries, the market is small due to lack of technological advancement, less priority from the government to healthcare and lawless environment due to events like Arab Spring. Some countries in this region do have a decent amount of technological advancement and doctors with modern education because of which, they can be suitable markets for 3D cell culture. Such countries are Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE), followed by rest of MEA region.

Inquire for Discount at: https://www.marketresearchfuture.com/check-discount/5928

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Home Healthcare Market Insights on Rising Trends and Technology Report 2018

Global Home Healthcare Market Research Report, by Product (Therapeutic products, Other), Service (Skilled Nursing Services, Respiratory Therapy Service, Other), Software (Clinical Management System, Telehealth Solution, Other) – Global Forecast Till 2023

The global home healthcare market is anticipated to expand at  8.1% CAGR from 2017 to 2023 (forecast period), according to the latest report by Market Research Future (MRFR). Home healthcare is an increasing viable option being preferred by patients owing to increasing healthcare costs and the burgeoning geriatric population. Home healthcare provides a range of services including physical therapy, speech therapy, occupational therapy, and skilled nursing. The digitization of data has made it simpler for patients to contact physicians and clinicians and gain an accurate diagnosis from the comforts of their home.

Technological advances in healthcare and diagnosis equipment and government initiatives encouraging home healthcare are likely to fuel market demand in the forthcoming years. Taking a cue from patient demands, players such as Philips have launched wireless solutions. This is evident by the introduction of CarePoint 5.0, a easy-to-use nurse call system for senior citizens in assisted living facilities and bedridden patients recuperating at home. But concerns regarding patient safety can impede market growth.

Avail Sample For this Report at: https://www.marketresearchfuture.com/sample_request/2030

Report Overview

The report covers the latest trends affecting the market to provide the most accurate forecasts and predictions. By correlating the historical data with key market dynamics, our analysts can make highly astute projections. MRFR’s report includes a thorough analysis of the global home healthcare market segmented by product, service, software, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.

Segment Overview

The global home healthcare market is segmented by product, service, software, and region. Products in the market include therapeutic and testing, screening, and monitoring products. The former is sub-segmented into dialysis equipment, respiratory therapy equipment, IV equipment, insulin delivery devices, wound care products, and others. On the other hand, the latter is segmented into holter and event monitors, pulse oximeters & heart rate monitors, sleep apnea monitors, blood glucose monitors, blood pressure monitors, cholesterol monitoring devices, and others.

Software discussed in the report designed to alleviate patient and hospital troubles include hospice solutions, telehealth solution, agency software, and clinical management systems. Based on services, the market is segmented into skilled nursing services, unskilled care services, respiratory therapy services, rehabilitation therapy services, infusion therapy services, and pregnancy care services.

The segments covered in the report are analyzed with respect to four major regions – North America, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. The definition and advantages of “home healthcare” is outlined in the report for a comprehensive understanding of the market. The report discusses in detail the various players and their respective strategies to enhance their value chain.

Brows Full Report at: https://www.marketresearchfuture.com/reports/home-healthcare-market-2030

Competitive Landscape

Some of the key players in the home healthcare market include Koninklijke Philips N.V. (The Netherlands), F. Hoffmann-La Roche AG (Switzerland), A&D Company (Japan), Fresenius SE & Co KGaA (Germany), Abbott (U.S.), GE Healthcare (U.S.), McKesson Corporation (U.S.), B. Braun Melsungen AG (Germany), Becton Dickinson Company (U.S.), Omron Corporation (Japan), Medtronic PLC (U.S.), LG Electronics (South Korea), Kinnser Software (U.S.), Apple (U.S.), 3M (U.S.), and others. These players are engaged in partnerships to launch new products in the market and expand their consumer base.

For the scope of research, the report offers a comprehensive analysis of the global home healthcare market.

Product

  • Testing, Screening, & Monitoring Products
    • Sleep Apnea Monitors
    • Pulse Oximeters & Heart Rate Monitors
    • Cholesterol Monitoring Devices
    • Holter and Event Monitors
    • Blood Pressure Monitors
    • Blood Glucose Monitors
    • Others
  • Therapeutic Products
    • Dialysis Equipment
    • Wound Care Products
    • Respiratory Therapy Equipment
    • Insulin Delivery Devices
    • IV Equipment
    • Others

About Market Research Future:  
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.  



Contact 
Market Research Future  
Office No. 528,  
Amanora Chambers Magarpatta Road,  
Hadapsar,  Pune – 411028  
Maharashtra,  
India  +1 646 845 9312

Global Ambulatory Services Market” - Market Analysis, Scope, Stake, Progress, Trends and Forecast up to 2022

Pune, India, September, 2018/MRFR Press Release/- Market Research Future published a cooked research report on “Global Ambulatory Services Market” – Market Analysis, Scope, Stake, Progress, Trends and Forecast up to 2022

Ambulatory service or ambulatory care is a broad term used to describe medical care performed at the OPDs or on an outpatient basis, without admission to a hospital or other facility.  Ambulatory Services Centers only treat patients with chronic or non-severe acute conditions providing dialysis clinics, ambulatory surgical centers, hospital outpatient departments, and others.

Many medical procedures and surgeries once provided in hospitals have shifted to ambulatory services thanks to technology advancements. Ambulatory services executives coordinate all aspects of outpatient care instead of Doctors and Nurses, making sure the ASC has the strong clinical, financial, and operational footing needed to deliver top-notch patient services.

Besides, rapidly undergoing through transformations, advancements in genetics, biomedical, and information technology; Healthcare sector is ushering towards effective personalized treatments for the patients. Simultaneously, accepting the customer-centric approach HC sector today strives to create positive consumer experiences. And to suffice this, the sector prompts extensive demand & wide uptake of Ambulatory Services. Resultantly, the market is increasing pervasively.

Acknowledging the exponential growth, the market is observing currently; Market Research Future (MRFR) in its recently published study report asserts that the global Ambulatory Services market is forecasted to reach over 3350 Bn. USD by 2022 growing at a CAGR of 5.1 % from 2017 to 2022.

Avail Sample for this Report at: https://www.marketresearchfuture.com/sample_request/2491

Additional factors providing impetus to the market growth include; growing population & urbanization.  Wide uptake of advanced technologies, availability of infrastructure for implementation of Ambulatory Care.

Global Ambulatory Services Market – Geographical Analysis

North America region accounts for the leading market for Ambulatory Services, acquiring the largest as in, 41.2% of the market share in the global market in the year 2016. The market in the region is further expected to grow at 4.8% CAGR during the forecast period.

Various factors substantiating the market growth include the availability of specialized technique, the presence of large number of ambulatory centers, solid support from the government and various organizations, high patient fulfillment with high quality and low-cost services in the region

Europe & Asia Pacific region accounts for the second & third largest market respectively in the global Ambulatory Services market. The Ambulatory Services market in Europe is expected to grow at a CAGR of 5.3% over the assessment period (2017 to 2022).

Whereas, the increasing patient pool coupled with the demand for more Ambulatory Services Centers drive the market growth in the APAC region. Owing to the rising funding and proliferating infrastructures for healthcare, mainly in countries like China and India the Asia Pacific market is emerging as one of the lucrative markets, globally.  The Ambulatory Services market in the APAC is projected to grow at 5.5% CAGR over the review period.

The MEA Region (the Middle East & Africa) will perceive a steady growth during the forecast period.

Access Report @ https://www.marketresearchfuture.com/reports/ambulatory-services-market-2491

Global Ambulatory Services Market – Competitive Landscape

The market of Ambulatory Services is fragmented and fiercely competitive with the presence of several big & small players forming a competitive edge. These players try to gain competitive advantage through acquisition, strategic partnership, collaboration, expansion, and product & technology launch. To achieve their goals, they invest heavily in the development of facilities.

Key Players:

Some of the leaders driving the global ambulatory services market include Surgical Care Affiliates, AmSurg Corp, Surgery Partners, Healthway Medical Group, HCA Holdings, Inc., SurgCenter, and Trillium Health Partners.                                         

Industry/Innovation/Related News:

September 4, 2018 – HCA Healthcare Inc. (US), a large operator of healthcare facilities ‘for-profit’ announced the acquisition of North Cypress Medical Center (Houston Area). The deal including four freestanding emergency centers in Barker Cypress, Spring Cypress, Fairfield, and Texas, signifies the expansion of HCA’ care in northwest Houston. Although the deal has no significance to make a large acquisition in order to expand its ambulatory surgery center business, HCA states that it has been selectively adding to the number of ASCs it operates.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Sterility Testing Market is registering a fabulous 11.7% CAGR during forecast period

Global Sterility Testing Market is creating opportunities for manufacturers and distributors. In addition, demand for effective vaccines to combat chronic maladies is anticipated to bode well for the market. Development of filtration systems to expedite drug development can positively impact the market. For instance, Merck launched the Stericup Quick Release system in 2017 for faster filtration of reagents, buffers, and media.

The global sterility testing market size is expected to touch USD 1,245.2 million by 2023 owing to rising sales of cars. Market Research Future’s (MRFR) latest study reveals that the market is predicted an 11.7% CAGR during the forecast period (2017–2023). High prevalence of chronic diseases and cardiovascular maladies is the primary factor driving market growth. Booming pharmaceutical and biotechnology sectors, funding provided by governments, and rising investments in the life science sector are other factors expected to elicit market demand over the forecast period.

Some of the key players profiled in the market report include Boston Scientific Corporation, Pacific BioLabs Inc., Becton, Dickinson and Company, Sartorius AG, Charles River Laboratories Inc., Belimed Deutschland GmbH, Merck KGaA, Thermo Fisher Scientific Inc., Astell Scientific, WuXi AppTec, Baxter BioPharma Solutions, Bioquell U.K. Ltd., SGS SA, BioMérieux SA, and others. Acquisitions, collaborations, and launch of new products are strategies employed by these players to acquire a larger market share.

Avail Sample For this Report at: https://www.marketresearchfuture.com/sample_request/547

MRFR’s report offers a detailed segmental analysis of the market based on product type, test type, end-user, and region. By product type, the market has been segmented into

  • consumables
  • instruments
  • and services.

Services are further segmented into

  • stability testing
  • sterility assurance tests
  • cleaning and disinfection
  • sterility validations.

The sterility assurance test segment is anticipated to be worth USD 151.6 million by 2023.

By test type, the market is segmented into

  • product flush sterility testing,
  • direct transfer sterility testing,
  • membrane filtration sterility testing,

The membrane filtration sterility testing segment can touch a valuation of USD 348.6 million by 2023. Membrane filtration is a method used in filtering microorganisms or bacteria capable of infecting solutions. Benefits such as testing in large volumes and inhibiting bacterial growth are expected to spur segment growth till 2023.

Major end-users include academic and research laboratories, hospitals and clinics, pharmaceutical companies, and others. The pharmaceutical companies segment is projected to register a 12.1% CAGR over the forecast period. Rising demand for sterile injectables is expected to fuel segment demand.

Access Report @ https://www.marketresearchfuture.com/reports/sterility-testing-market-547

Regional Outlook

The sterility testing market, on the basis of region, is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The Americas are expected to dominate the global market owing to the large patient population and demand for sterile drugs. Growth witnessed in domestic biotechnology and pharmaceutical sectors coupled with increased healthcare spending allotted to states are factors anticipated to fuel market growth over the forecast period.

Europe is predicted to be the second largest market, followed by APAC. Presence of well-established healthcare infrastructure, huge patient pool, and investments in life sciences can elicit huge market demand during the forecast period. Developed nations such as France, the U.K., and Italy are expected to contribute to overall market revenue.

The APAC sterility testing market is projected to showcase a robust CAGR over the forecast period owing to strong economies of Indian and China. It can enjoy good market demand owing to the presence of various contract manufacturing organizations.

The MEA market commands a smaller market share compared to others owing to stringent government policies and less emphasis on healthcare expenditure. The Middle East region is highly lucrative owing to the presence of nations such as Kuwait, Dubai, Qatar, and others.

Global Market for Sterility Testing – Competitive Dashboard

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hospital Beds Market Expected to reach USD 4,824.2 million by 2023 with growing Technology and Trends

Hospital Beds Market are specially designed for hospitalized patients who are in need of some form of health care services. Different types of hospital beds are available in the market such as advanced electric and semi electric beds. Increasing prevalence of diseases, rising geriatric population, and increasing number of hospitals & clinics drive the     growth of the market. According to the WHO, the number of people aged over 65 was approximately 524 million in 2010, which will reach 1.5 billion by 2050. Furthermore, increasing healthcare spending have fuelled the market growth. However, high cost of the advanced hospitals beds such as electric and semi-electric beds may slow the growth of the market during the forecasted period.

The global hospital beds market is growing at a stable pace and is expected to reach USD 4,824.2 million by 2023 from USD 2,515.1 million in 2016 at a CAGR of 5.5% during the forecasted period 2017-2023.

Avail Sample For this Report at: https://www.marketresearchfuture.com/sample_request/898

Some of the Major key players in the Hospital Beds Market: Hill-Rom Holdings, Stryker Corporation, Linet spol. sro., Invacare Corporation, Paramount Bed Holdings Co., Ltd., Gendron Inc., and Getinge AB.       

Hill-Rom Holdings, headquartered in Batesville, Indiana, the US, is one of the leading global medical technology company. In 2017, the company announced the launch of the new Hill-Rom 900 Accella bed system for higher acuity patients in intensive and acute care settings.

The global hospital beds market is majorly segmented on the basis of type,

  • power
  • end users

On the basis of types, the global hospital beds market is segmented into

  • acute care
  • long-term care
  • psychiatric & bariatric care
  • others (maternity and rehabilitation beds).

Based on the power, the market is segmented into

  • electric bed
  • semi-electric bed
  • manual bed.

Based on end users, the global hospital beds market is segmented into hospital, clinics, ambulatory, and others.

Taste the market data and market information presented through more than 140 market data tables and figures spread over 118 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “hospital beds market research report–Global forecast till 2023″ at https://www.marketresearchfuture.com/reports/hospital-bed-market-898 

The global hospital beds market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

Europe holes the largest share of the global hospital beds market due to increasing government support and high healthcare spending. Moreover, continuous technological development and the growing presence of the global market leaders contribute to the market growth. The Americas is the second largest market due to strong economic conditions, huge geriatric population, and well-developed healthcare sector. Moreover, improving reimbursement policies is expected to fuel the growth of this market.

About Market Research Future:                                                                                   

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: salesteam@marketresearchfuture.com

Wound Care Market to reach a value over USD 28 Bn by 2027 to thrive moderately at 6.20% CAGR

Global Wound Care Market resonates strong growth opportunities and is prognosticated to exhibit healthy growth in the forthcoming years. Market Research Future (MRFR)’s latest study reveals that the global wound care market is projected to thrive moderately at 6.20% CAGR during the forecast period 2017 to 2027. The global market is estimated to reach a value over USD 28 Mn by 2027 up from USD 15,456.2 Mn in 2016.

The rising incidences of chronic wounds have intensified the need for developments in the wound care product offerings. For instance, Negative Pressure Wound Therapy (NPWT) has emerged as an effective therapy for progressive wound management. According to the World Health Organization (WHO), in 2014, 9% of the world’s deaths were caused due to injuries. Additionally, increasing count of surgeries is another major factor aiding the expansion of the market.

Industry Major Key Player Analysis: Some of the key players profiled in the report include B. Braun Melsungen AG, 3M, Baxter, Ethicon, Inc, Smith & Nephew, ConvaTec, and Kinetic Concepts, Inc

Avail Sample for this Report at: https://www.marketresearchfuture.com/sample_request/926

The shift towards advanced wound care products has opened avenues of growth opportunities for the market participants. The large-scale adoption of the advanced wound care products is attributable to its effectiveness and efficacy in the treatment of wounds. However, the developing economies drive the demand for traditional wound care products owing to low cost and easy availability.

Global Market for Wound Care-Segmental Analysis:

By type, the market is segmented into

  • chronic wound
  • acute wound.

The chronic wound segment held the largest share of the market, which accounted for 60.3% of share, in 2016. It is likely to retain a significant share of the market over the next few years.

By application, the market has been segmented into

  • surgical wound
  • ulcer, burn
  • trauma wounds

Among these, the surgical wound segment is estimated to witness a surge in demand and reach a value over USD 10 Mn by the end of 2027.

By end-user, the global market is segmented into

  • hospitals
  • clinics
  • home health care
  • trauma centers

The hospitals segment captured the most substantial share of the market in 2016. It is prognosticated to retain its prominence and register a CAGR of over 6% during the forecast period.

Access Report @ https://www.marketresearchfuture.com/reports/wound-care-market-926

Geographically, Global Wound Care Market Segmented  as,

By region, the global wound care market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas held the largest share of the market in 2016 which accounted for 55.8% share. The valuation of the market is projected to reach a little over USD 16 Mn by 2027-end up from USD 8,621.4 Mn in 2016. The growth of the regional market is attributable to the development of wound care products, growing diabetic population, and rising geriatric population. Meanwhile, Asia Pacific is poised to exhibit a relatively higher CAGR through the assessment period owing to the presence of opportunities for the development of the market. Europe is an important growth pocket and is projected to remain highly lucrative market in the foreseeable future. Meanwhile, the Middle East & Africa is estimated to account for the least share of the global market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Page 2 of 4

Powered by WordPress & Theme by Anders Norén